Modelling relapse in patients with high-risk localised prostate cancer treated randomly in the GETUG 12 phase III trial reveals two populations of relapsing patients
Journal article published in 2016 by
C. Vicier,
L. Faivre 
,
F. Lesaunier,
R. Delva,
G. Gravis,
F. Rolland,
F. Priou,
C. Theodore,
I. Krakowski,
J.-M. Ferrero,
J.-F. Berdah,
N. Houede,
M. Baciuchka,
B. Laguerre,
L. Mourey
and other authors.
,
F. Lesaunier,
R. Delva,
G. Gravis,
F. Rolland,
F. Priou,
C. Theodore,
I. Krakowski,
J.-M. Ferrero,
J.-F. Berdah,
N. Houede,
M. Baciuchka,
B. Laguerre,
L. Mourey
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 